BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10235032)

  • 21. Methotrexate for rheumatoid arthritis: what should the patient be told?
    Ostor AJ; O'Gradaigh DR; Jenner JR
    Rheumatology (Oxford); 2003 Dec; 42(12):1576-8. PubMed ID: 14645872
    [No Abstract]   [Full Text] [Related]  

  • 22. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.
    Roos JC; Chilvers ER; Ostor AJ
    J Rheumatol; 2007 Jan; 34(1):238-9; author reply 239. PubMed ID: 17216703
    [No Abstract]   [Full Text] [Related]  

  • 23. Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases.
    Roux N; Flipo RM; Cortet B; Lafitte JJ; Tonnel AB; Duquesnoy B; Delcambre B
    Rev Rhum Engl Ed; 1996 Jun; 63(6):453-6. PubMed ID: 8817757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methotrexate pneumonitis. Important to minimize serious adverse effects in treatment of rheumatoid arthritis].
    Sturfelt G
    Lakartidningen; 1994 Jun; 91(26-27):2571-2. PubMed ID: 8046973
    [No Abstract]   [Full Text] [Related]  

  • 25. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis.
    van der Veen MJ; Dekker JJ; Dinant HJ; van Soesbergen RM; Bijlsma JW
    J Rheumatol; 1995 Sep; 22(9):1766-8. PubMed ID: 8523359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.
    Salaffi F; Manganelli P; Carotti M; Subiaco S; Lamanna G; Cervini C
    Clin Rheumatol; 1997 May; 16(3):296-304. PubMed ID: 9184269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
    Ohosone Y; Okano Y; Kameda H; Fujii T; Hama N; Hirakata M; Mimori T; Akizuki M; Ikeda Y
    J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe interstitial pneumonitis associated with infliximab therapy.
    Chatterjee S
    Scand J Rheumatol; 2004; 33(4):276-7. PubMed ID: 15370726
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis.
    Gaffo AL; Alarcón GS
    Arch Intern Med; 2008 Sep; 168(17):1927-8. PubMed ID: 18809822
    [No Abstract]   [Full Text] [Related]  

  • 30. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis.
    Clewes AR; Dawson JK
    Rheumatology (Oxford); 2004 Aug; 43(8):1059-60; author reply 1060. PubMed ID: 15258299
    [No Abstract]   [Full Text] [Related]  

  • 31. Sustained cough in methotrexate therapy for rheumatoid arthritis.
    Schnabel A; Dalhoff K; Bauerfeind S; Barth J; Gross WL
    Clin Rheumatol; 1996 May; 15(3):277-82. PubMed ID: 8793260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of rheumatoid arthritis complicated with methotrexate-induced pneumonitis and pneumocystis pneumonia].
    Minagawa S; Takayanagi N; Hara K; Takaku Y; Tsutiya Y; Hijikata N; Yamaji T; Tokunaga D; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y; Kawabata Y
    Nihon Kokyuki Gakkai Zasshi; 2008 Mar; 46(3):237-42. PubMed ID: 18409573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additional barriers to clinical supervision for allied health professionals working in regional and remote settings.
    Matthews R
    Aust Health Rev; 2014 Feb; 38(1):118. PubMed ID: 24479990
    [No Abstract]   [Full Text] [Related]  

  • 34. Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis.
    Taniguchi K; Usui Y; Matsuda T; Suzuki S; Fujiki K; Yakusiji F; Tomiyama J; Kinoshita K; Ilzuka H; Kuga Y
    Int J Clin Pharmacol Res; 2005; 25(3):101-5. PubMed ID: 16366417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports.
    Hargreaves MR; Mowat AG; Benson MK
    Thorax; 1992 Aug; 47(8):628-33. PubMed ID: 1412121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adverse effects of DMARDs in treatment of rheumatoid arthritis].
    Sugii S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():566-72. PubMed ID: 15799419
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
    Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
    Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit and risk of methotrexate treatment in rheumatoid arthritis.
    Rau R; Herborn G
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S83-94. PubMed ID: 15552520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe acute pneumopathy following low-dose methotrexate therapy in chronic polyarthritis].
    Quadri F; Marone C
    Schweiz Med Wochenschr; 1989 Oct; 119(41):1434-6. PubMed ID: 2799349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia].
    Shimada T; Nishimura Y; Funada Y; Takenaka K; Kobayashi K; Urata Y; Yosimura S; Nishiuma T; Satouchi M; Yokoyama M
    Arerugi; 2004 Jun; 53(6):575-81. PubMed ID: 15247519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.